The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: Tendinopathy is very common in the general population. There are increasing numbers of clinical studies referring to platelet-rich plasma (PRP) and platelet-poor plasma (PPP) as treatments for tendinopathy. Purpose: To perform a meta-analysis of the outcomes of the PRP groups by preparation method and injection technique in tendinopathy. To determine the clinical effectiveness of the preparations and to evaluate the effect of controls used in the studies reviewed. Study Design: Systematic review and meta-analysis. Methods: The PubMed, EMBASE, CINAHL, and Medline databases were searched in March 2012, April 2014, and August 2015, and randomized controlled trials using autologous blood, PRP, PPP, or autologous conditioned plasma in tendinopathy with outcome measures of pain and follow-up time of 3 months were included in this review. Trials including surgery, tendon tears, and muscle or ligament injuries were excluded. Study quality was assessed using the Cochrane Collaboration risk-of-bias tool by 2 reviewers. Data were pooled using random-effects meta-analysis. The primary outcome measure was a change in pain intensity. Where more than 1 pain scale was included, a functional score was selected ahead of a visual analog scale score. Results: A total of 18 studies (1066 participants) were included. Eight studies were deemed to be at low risk of bias. The most significant outcomes in the PRP groups were seen in those treated with highly cellular leukocyte-rich PRP (LR-PRP) preparations: GPS kit (standardized mean difference [SMD], 35.75; 95% CI, 28.40-43.10), MyCells kit (SMD, 31.84; 95% CI, 17.56-46.13), Prosys kit (SMD, 42.99; 95% CI, 37.73-48.25), and unspecified LR-PRP (SMD, 34.62; 95% CI, 31.69-37.55). When the LR-PRP system types were grouped, there was a strongly positive effect (SMD, 36.38; 95% CI, 34.00-38.77) when compared with leukocyte-poor PRP (SMD, 26.77; 95% CI, 18.31-35.22). In assessing the control groups, there was no clear difference between different types of control injections: saline (SMD, 14.62; 95% CI, 10.74-18.50), local anesthetic (SMD, 15.00; 95% CI, 7.66-22.34), corticosteroid (SMD, 23.82; 95% CI, 10.74-18.50), or dry needling (SMD, 25.22; 95% CI, 21.27-29.16). Conclusion: There is good evidence to support the use of a single injection of LR-PRP under ultrasound guidance in tendinopathy. Both the preparation and intratendinous injection technique of PRP appear to be of great clinical significance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
Stewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134
Treatment of Chronic Elbow Tendinosis with Buffered Platelet-Rich Plasma
Mishra, A., & Pavelko, T. (2006) · The American Journal of Sports Medicine · doi:10.1177/0363546506288850 · Cited by 913
Coombes, B. K., Bisset, L., & Vicenzino, B. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61160-9 · Cited by 860
Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy: A Randomized Controlled Trial
de Vos, R. J., Weir, A., van Schie, H. T. M., Bierma-Zeinstra, S. M. A., Verhaar, J. A. N., Weinans, H., & Tol, J. L. (2010) · JAMA · doi:10.1001/jama.2009.1986 · Cited by 834
Peerbooms, J. C., Sluimer, J., Bruijn, D. J., & Gosens, T. (2010) · The American Journal of Sports Medicine · doi:10.1177/0363546509355445 · Cited by 689
Platelet-Rich Plasma: The PAW Classification System
DeLong, J. M., Russell, R. P., & Mazzocca, A. D. (2012) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2012.04.148 · Cited by 623
The pathogenesis of tendinopathy. A molecular perspective
Riley, G. (2004) · Rheumatology · doi:10.1093/rheumatology/keg448 · Cited by 543
Gosens, T., Peerbooms, J. C., van Laar, W., & den Oudsten, B. L. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546510397173 · Cited by 530
Platelet-Rich Plasma Differs According to Preparation Method and Human Variability
Mazzocca, A. D., McCarthy, M. B. R., Chowaniec, D. M., Cote, M. P., Romeo, A. A., Bradley, J. P., Arciero, R. A., & Beitzel, K. (2012) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.k.00430 · Cited by 508
Mishra, A. K., Skrepnik, N. V., Edwards, S. G., Jones, G. L., Sampson, S., Vermillion, D. A., Ramsey, M. L., Karli, D. C., & Rettig, A. C. (2014) · The American Journal of Sports Medicine · doi:10.1177/0363546513494359 · Cited by 396
de Jonge, S., de Vos, R. J., Weir, A., van Schie, H. T. M., Bierma-Zeinstra, S. M. A., Verhaar, J. A. N., Weinans, H., & Tol, J. L. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511404877 · Cited by 371
Krogh, T. P., Fredberg, U., Stengaard-Pedersen, K., Christensen, R., Jensen, P., & Ellingsen, T. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546512472975 · Cited by 356
Thanasas, C., Papadimitriou, G., Charalambidis, C., Paraskevopoulos, I., & Papanikolaou, A. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511417113 · Cited by 351
Platelet-rich therapies for musculoskeletal soft tissue injuries
Moraes, V. Y., Lenza, M., Tamaoki, M. J., Faloppa, F., & Belloti, J. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010071.pub3 · Cited by 344
Dragoo, J. L., Wasterlain, A. S., Braun, H. J., & Nead, K. T. (2014) · The American Journal of Sports Medicine · doi:10.1177/0363546513518416 · Cited by 336
Fredberg, U., & Stengaard‐Pedersen, K. (2008) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2007.00746.x · Cited by 322
Rha, D.-W., Park, G.-Y., Kim, Y.-K., Kim, M. T., & Lee, S. C. (2013) · Clinical Rehabilitation · doi:10.1177/0269215512448388 · Cited by 305
Kesikburun, S., Tan, A. K., Yılmaz, B., Yaşar, E., & Yazıcıoğlu, K. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546513496542 · Cited by 301
Creaney, L., Wallace, A., Curtis, M., & Connell, D. (2011) · British Journal of Sports Medicine · doi:10.1136/bjsm.2010.082503 · Cited by 280
IOC consensus paper on the use of platelet-rich plasma in sports medicine
Engebretsen, L., Steffen, K., Alsousou, J., Anitua, E., Bachl, N., Devilee, R., Everts, P., Hamilton, B., Huard, J., Jenoure, P., et al. (2010) · British Journal of Sports Medicine · doi:10.1136/bjsm.2010.079822 · Cited by 279
Platelet-Rich Plasma Versus Focused Shock Waves in the Treatment of Jumper’s Knee in Athletes
Vetrano, M., Castorina, A., Vulpiani, M. C., Baldini, R., Pavan, A., & Ferretti, A. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546513475345 · Cited by 271
Dean, B. J. F., Lostis, E., Oakley, T., Rombach, I., Morrey, M. E., & Carr, A. J. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.08.006 · Cited by 245
Krogh, T. P., Bartels, E. M., Ellingsen, T., Stengaard-Pedersen, K., Buchbinder, R., Fredberg, U., Bliddal, H., & Christensen, R. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546512458237 · Cited by 239
Autologous growth factor injections in chronic tendinopathy: a systematic review
de Vos, R. J., van Veldhoven, P. L. J., Moen, M. H., Weir, A., Tol, J. L., & Maffulli, N. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq006 · Cited by 197
de Vos, R.-J., Windt, J., & Weir, A. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-093281 · Cited by 186
Scott, A., Docking, S., Vicenzino, B., Alfredson, H., Zwerver, J., Lundgreen, K., Finlay, O., Pollock, N., Cook, J. L., Fearon, A., et al. (2013) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-092329 · Cited by 186
What are the validated animal models for tendinopathy?
Lui, P. P. Y., Maffulli, N., Rolf, C., & Smith, R. K. W. (2011) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2010.01164.x · Cited by 168
Gautam, V., Verma, S., Batra, S., Bhatnagar, N., & Arora, S. (2015) · Journal of Orthopaedic Surgery · doi:10.1177/230949901502300101 · Cited by 159
Wolf, J. M., Özer, K., Scott, F., Gordon, M. J. V., & Williams, A. E. (2011) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2011.05.014 · Cited by 156
Platelet-Rich Plasma in Tendon Models: A Systematic Review of Basic Science Literature
Baksh, N., Hannon, C. P., Murawski, C. D., Smyth, N. A., & Kennedy, J. G. (2013) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2012.10.025 · Cited by 154
Carofino, B., Chowaniec, D. M., McCarthy, M. B., Bradley, J. P., Delaronde, S., Beitzel, K., Cote, M. P., Arciero, R. A., & Mazzocca, A. D. (2012) · Arthroscopy · doi:10.1016/j.arthro.2011.09.013 · Cited by 147 · cited 2×
“Given the potential negative effect of local anesthetic on PRP, this may be the reason that this group performed poorly.(7) In assessing the control groups, there was no clear difference between different types of control injections: saline (SMD, 14.”
BackgroundKazemi, M., Azma, K., Tavana, B., Moghadam, F. R., & Panahi, A. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181ddcb31 · Cited by 137
Gosens, T., Den Oudsten, B. L., Fievez, E., van ‘t Spijker, P., & Fievez, A. (2012) · International Orthopaedics · doi:10.1007/s00264-012-1540-7 · Cited by 136
Stenhouse, G., Sookur, P., & Watson, M. J. (2013) · Skeletal Radiology · doi:10.1007/s00256-013-1691-7 · Cited by 100
Bell, K. J., Fulcher, M. L., ROWLANDS, D. S., & Kerse, N. M. (2013) · BMJ · doi:10.1136/bmj.f2310 · Cited by 95
Özturan, K. E., Yücel, İ., Çakıcı, H., Güven, M., & Sungur, İ. (2010) · Orthopedics · doi:10.3928/01477447-20100104-09 · Cited by 93
Behera, P., Dhillon, M., Aggarwal, S., Marwaha, N., & Prakash, M. (2015) · Journal of Orthopaedic Surgery · doi:10.1177/230949901502300102 · Cited by 83
Autologous Blood Injection to Treat Achilles Tendinopathy? A Randomized Controlled Trial
Pearson, J., ROWLANDS, D. S., & Highet, R. M. (2012) · Journal of Sport Rehabilitation · doi:10.1123/jsr.21.3.218 · Cited by 41
Inoue, M., Hojo, T., 中島, 美., Kitakoji, H., & Itoi, M. (2009) · Acupuncture in Medicine · doi:10.1136/aim.2009.001164 · Cited by 24
Cited by
Chen, X., Jones, I. A., Park, C., & Vangsness, C. T. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517743746 · Cited by 294
Limiting angiogenesis to modulate scar formation
Korntner, S., Lehner, C., Gehwolf, R., Wagner, A., Grütz, M., Kunkel, N., Tempfer, H., & Traweger, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.02.010 · Cited by 172
Scott, A., LaPrade, R. F., Harmon, K. G., Filardo, G., Kon, E., Della Villa, S., Bahr, R., Moksnes, H., Torgalsen, T., Lee, J., et al. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546519837954 · Cited by 170
“A misconception that occasionally arises among readers of clinical trials is that any observed improvement over time (ie, in comparison with baseline) represents a treatment effect: this misconception can sometimes lead to mistaken interpretations of treatment effectiveness.(13) Improvement over time is to be expected…”
BackgroundKwong, C. A., Woodmass, J. M., Gusnowski, E. M., Bois, A. J., Leblanc, J., More, K. D., & Lo, I. K. Y. (2021) · Arthroscopy · doi:10.1016/j.arthro.2020.10.037 · Cited by 126
Everts, P. A., Mazzola, T., Mautner, K., Randelli, P. S., & Podesta, L. (2022) · Biomedicines · doi:10.3390/biomedicines10112933 · Cited by 34
Metadata
- Authors
- Fitzpatrick, J., Bulsara, M., & Zheng, M. H.
- Venue
- The American Journal of Sports Medicine
- Publisher
- SAGE Publications
- Published
- 2016-07-21
- Volume
- 45
- Issue
- 1
- Pages
- 226-233
- ISSN
- 0363-5465 (ISSN-L)
- 1552-3365
- OpenAlex
- W2410527853
- Cited by
- 340
- References
- 42
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.